Profiling of time-dependent human plasma protein adsorption on non-coated and heparin-coated oxygenator membranes.

[1]  C. Rodriguez-Emmenegger,et al.  Complement Activation Dramatically Accelerates Blood Plasma Fouling On Antifouling Poly(2-Hydroxyethyl Methacrylate) Brush Surfaces. , 2021, Macromolecular bioscience.

[2]  M. Avci-Adali,et al.  A Novel C1-Esterase Inhibitor Oxygenator Coating Prevents FXII Activation in Human Blood , 2020, Biomolecules.

[3]  P. Tengvall,et al.  The blood compatibility challenge Part 2: protein adsorption phenomena governing blood reactivity. , 2019, Acta biomaterialia.

[4]  B. Maček,et al.  Quantitative Proteomics Links the Intermediate Filament Nestin to Resistance to Targeted BRAF Inhibition in Melanoma Cells* , 2019, Molecular & Cellular Proteomics.

[5]  R. Biran,et al.  Heparin coatings for improving blood compatibility of medical devices☆ , 2017, Advanced drug delivery reviews.

[6]  J. Kinoshita,et al.  A Three-phase Approach for the Early Identification of Acute Lung Injury Induced by Severe Sepsis. , 2016, In vivo.

[7]  Katharina Landfester,et al.  Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. , 2016, Nature nanotechnology.

[8]  T. Renné,et al.  Contact system revisited: an interface between inflammation, coagulation, and innate immunity , 2016, Journal of thrombosis and haemostasis : JTH.

[9]  M. Thompson,et al.  A survey of state-of-the-art surface chemistries to minimize fouling from human and animal biofluids. , 2015, Biomaterials science.

[10]  C. Coopersmith,et al.  Clinical and billing review of extracorporeal membrane oxygenation. , 2015, Chest.

[11]  A. Fiane,et al.  Heparin‐coated cardiopulmonary bypass circuits selectively deplete the pattern recognition molecule ficolin‐2 of the lectin complement pathway in vivo , 2015, Clinical and experimental immunology.

[12]  P. Nilsson,et al.  Prediction of inflammatory responses induced by biomaterials in contact with human blood using protein fingerprint from plasma. , 2015, Biomaterials.

[13]  Hong Chen,et al.  Blood compatible materials: state of the art. , 2014, Journal of materials chemistry. B.

[14]  Andrew Emili,et al.  Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles. , 2014, ACS nano.

[15]  Gökhan Lafç,et al.  Use of extracorporeal membrane oxygenation in adults. , 2014, Heart, lung & circulation.

[16]  Robert H Bartlett,et al.  Extracorporeal Membrane Oxygenation Circuitry , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[17]  J. Biggerstaff,et al.  In vitro assessment of blood compatibility: Residual and dynamic markers of cellular activation , 2013, Journal of biomaterials applications.

[18]  J. Brash,et al.  Non-fouling biomaterials based on blends of polyethylene oxide copolymers and polyurethane: simultaneous measurement of platelet adhesion and fibrinogen adsorption from flowing whole blood , 2013, Journal of biomaterials science. Polymer edition.

[19]  J. Brash.  Protein Surface Interactions and Biocompatibility: A Forty Year Perspective , 2012 .

[20]  Shiping Zhu,et al.  Methacrylate polymer layers bearing poly(ethylene oxide) and phosphorylcholine side chains as non-fouling surfaces: in vitro interactions with plasma proteins and platelets. , 2011, Acta biomaterialia.

[21]  K. Kador,et al.  Sequential co-immobilization of thrombomodulin and endothelial protein C receptor on polyurethane: activation of protein C. , 2011, Acta biomaterialia.

[22]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[23]  R. Sommer,et al.  Proteogenomics of Pristionchus pacificus reveals distinct proteome structure of nematode models. , 2010, Genome research.

[24]  David F. Smith,et al.  Carbohydrate Recognition Properties of Human Ficolins , 2009, The Journal of Biological Chemistry.

[25]  Stephanie A. Smith,et al.  The cell-based model of coagulation. , 2009, Journal of veterinary emergency and critical care.

[26]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[27]  Y. Missirlis,et al.  Protein–material interactions: From micro-to-nano scale , 2008 .

[28]  S. Marasco,et al.  Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. , 2008, Heart, lung & circulation.

[29]  M. Mann,et al.  Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips , 2007, Nature Protocols.

[30]  T. Jokiranta,et al.  Localization of the third heparin-binding site in the human complement regulator factor H1. , 2006, Molecular immunology.

[31]  B. Nilsson,et al.  Surface-attached PEO in the form of activated Pluronic with immobilized factor H reduces both coagulation and complement activation in a whole-blood model. , 2006, Journal of biomedical materials research. Part A.

[32]  R. Müller,et al.  Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting. , 2005, International journal of pharmaceutics.

[33]  D. Meyer,et al.  A Polymethylpentene Fiber Gas Exchanger for Long-Term Extracorporeal Life Support , 2005, ASAIO journal.

[34]  Bo Nilsson,et al.  Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. , 2005, Biomaterials.

[35]  P. Lachmann,et al.  Initiation of complement activation , 2005, Springer Seminars in Immunopathology.

[36]  Michael V Sefton,et al.  Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. , 2004, Biomaterials.

[37]  Yukihiko Nosé,et al.  Development of the oxygenator: past, present, and future , 2004, Journal of Artificial Organs.

[38]  B. Nilsson,et al.  Optimal heparin surface concentration and antithrombin binding capacity as evaluated with human non-anticoagulated blood in vitro. , 2003, Journal of biomedical materials research. Part A.

[39]  J. Brash,et al.  Adsorption of proteins from infant and adult plasma to biomaterial surfaces. , 2002, Journal of biomedical materials research.

[40]  Clive D McFarland,et al.  Platelet adhesion to polystyrene-based surfaces preadsorbed with plasmas selectively depleted in fibrinogen, fibronectin, vitronectin, or von Willebrand's factor. , 2002, Journal of biomedical materials research.

[41]  Ying Jun Du,et al.  Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex. , 2002, Biomaterials.

[42]  Gerhard Ziemer,et al.  Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption. , 2002, Biomaterials.

[43]  B. Nilsson,et al.  Binding of a model regulator of complement activation (RCA) to a biomaterial surface: surface-bound factor H inhibits complement activation. , 2001, Biomaterials.

[44]  W. Tsai,et al.  The effect of adsorbed fibrinogen, fibronectin, von Willebrand factor and vitronectin on the procoagulant state of adherent platelets. , 2000, Biomaterials.

[45]  John D Lambris,et al.  Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics. , 2000, Immunopharmacology.

[46]  D. Gailani,et al.  Characterization of a Heparin Binding Site on the Heavy Chain of Factor XI* , 1998, The Journal of Biological Chemistry.

[47]  S. Meri,et al.  Complement Regulation , 1998, Vox sanguinis.

[48]  P. Tengvall,et al.  Studies on protein adsorption and activation of complement on hydrated aluminium surfaces in vitro. , 1998, Biomaterials.

[49]  F. Kronenberg,et al.  Rapid activation of the complement system by cuprophane depends on complement component C4. , 1998, Kidney international.

[50]  H. Verheul,et al.  Platelet: transporter of vascular endothelial growth factor. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[51]  Y. Zuo,et al.  Identification of the Antithrombin III Heparin Binding Site* , 1997, The Journal of Biological Chemistry.

[52]  E. Fosse,et al.  High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes. , 1995, The Annals of thoracic surgery.

[53]  B. Nilsson,et al.  Modification of the Complement Binding Properties of Polystyrene: Effects of End‐Point Heparin Attachment , 1993, Scandinavian journal of immunology.

[54]  E. Fosse,et al.  Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.

[55]  S. Meri,et al.  Localization of the heparin-binding site on complement factor H. , 1991, The Journal of biological chemistry.

[56]  J. Brash,et al.  Identification of plasma proteins adsorbed to hemodialyzers during clinical use. , 1989, Journal of biomedical materials research.

[57]  J. Anderson,et al.  Effect of albumin coating on the in vitro blood compatibility of Dacron arterial prostheses. , 1989, Biomaterials.

[58]  P. Wojciechowski,et al.  Phenomenology and mechanism of the transient adsorption of fibrinogen from plasma (Vroman effect) , 1986 .

[59]  R. Rosenberg,et al.  The binding properties of human complement component C1q. Interaction with mucopolysaccharides. , 1983, The Journal of biological chemistry.

[60]  A. Linker,et al.  Structure of the antithrombin-binding site in heparin. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[61]  A. L. Adams,et al.  Identification of rapid changes at plasma-solid interfaces. , 1969, Journal of biomedical materials research.